Stockreport

Zosano Pharma Announces US Patent Office Publication of “Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines”

Zosano Pharma Corporation  (ZSAN) 
Last zosano pharma corporation earnings: 11/9 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.zosanopharma.com
PDF US Patent Office has Published Patent Application for M207 Zolmitriptan Delivered Intracutaneously via Zosano’s Proprietary Adhesive Dermally-Applied Microarray (ADAM) T [Read more]